WEBULL
News
ASBPW
0.0299
-0.33%
-0.0001
Aspire Biopharma Reports Q3 2025 Update and Advances Sublingual Drug Delivery Programs
Reuters · 1d ago
ASPIRE BIOPHARMA HOLDINGS INC FILES FOR OFFERING OF UP TO 41.5 MLN SHARES BY SELLING SHAREHOLDER - SEC FILING
Reuters · 3d ago
Aspire Biopharma Submits Pre-IND Meeting Request to FDA for Sublingual Aspirin Product
Reuters · 3d ago
Weekly Report: what happened at ASBPW last week (1124-1128)?
Weekly Report · 5d ago
Aspire Biopharma Holdings Adds Dr. Mark J. Jaroszeski to Scientific Team
Reuters · 11/26 14:00
Weekly Report: what happened at ASBPW last week (1117-1121)?
Weekly Report · 11/24 10:46
Weekly Report: what happened at ASBPW last week (1110-1114)?
Weekly Report · 11/17 10:46
Aspire Biopharma Holdings Inc. Files Amendment to 10-Q Quarterly Report
Reuters · 11/14 22:03
Aspire Biopharma Holdings Inc. reports net revenue of $1,941 for Q3 2025
Reuters · 11/14 13:21
ASPIRE BIOPHARMA HOLDINGS INC - ON NOV 11, ENTERED ELOC AGREEMENT WITH ARENA BUSINESS SOLUTIONS - SEC FILING
Reuters · 11/14 13:02
ASPIRE BIOPHARMA HOLDINGS - UNDER ELOC AGREEMENT, CO HAS RIGHT BUT NOT OBLIGATION TO DIRECT ARENA TO PURCHASE UP TO $100 MLN OF CO’S STOCK
Reuters · 11/14 13:02
Aspire Biopharma Announces $100 Million Unregistered Share Sale Under Equity Line Agreement
Reuters · 11/14 13:01
Aspire Biopharma Holdings Inc. held special shareholder meeting
Reuters · 11/05 21:51
Aspire Biopharma Faces Nasdaq Delisting After Compliance Failures
Reuters · 10/17 21:16
Aspire Biopharma Holdings Announces Breakthrough in Sublingual Drug Delivery with New Patent Application
Reuters · 10/06 12:30
Aspire Biopharma Holdings Inc. to Present Pipeline Updates at Noble Capital Markets Emerging Growth Virtual Equity Conference
Reuters · 10/03 15:30
Aspire Biopharma Announces New Clinical Trials for Sublingual Aspirin and Rapid-Acting ED Medication, Eyes 2025–2026 FDA Submissions
Reuters · 10/01 12:30
Aspire Biopharma Holdings Inc. Raises $7.75 Million Through Private Placement in Two Tranches
Reuters · 09/26 21:11
Aspire Biopharma Holdings Inc. Announces Date for Special Stockholders Meeting
Reuters · 09/23 16:40
Aspire Biopharma Expands Production with SupraNaturals for Two Million Servings of BUZZ BOMB™ Supplement
Reuters · 09/16 12:31
More
Webull provides a variety of real-time ASBPW stock news. You can receive the latest news about Aspire Biopharma Holdings Inc through multiple platforms. This information may help you make smarter investment decisions.
About ASBPW
PowerUp Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. It has not selected any specific business combination target and has not engaged in any substantive discussions, directly or indirectly, with any business combination target. The Company intends to focus its search on a business within the interactive media, digital media, sports, entertainment, and/or leisure, with a particular focus on video gaming, gaming adjacent, and new metaverse video gaming businesses. The Company neither engages in any business operations nor generates any revenues.